Relmada Therapeutics Inc (RLMD) - News Archive

Relmada Therapeutics Unveils Promising Initial Phase 2 NDV-01 Data at AUA2025: A Glimpse into New Frontiers Against Bladder Cancer In a significant development in the fight against high-grade non-muscle invasive bladder...

Relmada Therapeutics Explores Strategic Alternatives to Maximize Shareholder ValueIn a significant move poised to reshape its operational landscape, Relmada Therapeutics, Inc. has officially announced that it has commen...

Relmada Therapeutics Inc. a biopharmaceutical company focused on developing innovative therapies for various diseases, recently announced the initiation of Phase 1 dosing of its proprietary psilocybin formulation, REL-P...

CSIMarket.com is pleased to present an analysis of Transcode Therapeutics Inc s performance in the biotechnology and medical research industry. This article aims to shed light on the company s market capitalization, gro...